Since most current studies have focused on exploring how phagocyte internalization of drug-
loaded nanovesicles by macrophages would affect the function and therapeutic effects of …

Alveolar macrophages play a crucial role in the initiation and resolution of the immune
response in the lungs. Pro-inflammatory M1 alveolar macrophages are an interesting target …

Abstract Acute Respiratory Distress Syndrome (ARDS), associated with Covid-19 infections,
is characterized by diffuse lung damage, inflammation and alveolar collapse that impairs …

Acute respiratory distress syndrome (ARDS) has been a life threat for patients in ICUs. Vast
efforts have been devoted, while no medication has proved viable, which may be ascribed to …

Acute lung injury (ALI) is one of the most common comorbidities associated with sepsis and
can lead to acute respiratory distress syndrome. Intense inflammatory response due to …

Lung bacterial infections could result in acute lung inflammation/injury (ALI) that propagates
to its severe form, acute respiratory distress syndrome (ADRS) leading to the death. The …

Liposomes are promising vectors for pulmonary drug delivery, and have been used in
marketed inhalation products. Membrane fluidity is an important property of liposomes …

Diseases of the pulmonary alveolus, such as pulmonary fibrosis, are leading causes of
morbidity and mortality, but exceedingly few drugs are developed for them. A major reason …

Nanomedicine holds immense potential for therapeutic manipulation of phagocytic immune
cells. However, in vitro studies often fail to accurately translate to the complex in vivo …

Uncontrolled inflammation is a major pathological factor underlying a range of diseases
including autoimmune conditions, cardiovascular disease, and cancer. Improving localized …